Empowering Cancer Diagnostics: Key Drivers Behind the Growth of the MRD Testing Market
The global market for minimal residual disease (MRD) testing is experiencing significant growth, driven by the increasing prevalence of cancer, especially blood cancers, high recurrence rates in various cancer types, and increased investments in MRD research. The demand for MRD testing is expected to expand further as personalized treatments and targeted oncology therapies gain traction,...
0 Kommentare 0 Anteile 309 Ansichten